{"id":"W2039223287","doi":"10.1177/00912700122012751","title":"Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody‐Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse","year":2001,"lang":"en","type":"article","venue":"The Journal of Clinical Pharmacology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"ca_institutions":"Women's Health Research Institute","funders":"","keywords":"Gemtuzumab ozogamicin; Calicheamicin; Pharmacokinetics; CD33; Medicine; Pharmacology; Myeloid leukemia; Radioimmunotherapy; Chemotherapy; Antibody; Internal medicine; Monoclonal antibody; Immunology; Stem cell; CD34","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003551795,0.0002397029,0.0007513941,0.0001599106,0.0002050696,0.0004779065,0.0001583026,0.0003133543,0.0004993491],"category_scores_gemma":[0.0008756283,0.0001937349,0.0002513559,0.0001508197,0.0001683462,0.0002447788,0.0001208347,0.0006169183,0.0001921124],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007880086,"about_ca_system_score_gemma":0.0003719189,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007655892,"about_ca_topic_score_gemma":0.001538899,"domain_scores_codex":[0.9998367,0.00005395987,0.000008367425,0.00002822054,0.00004115866,0.0000317054],"domain_scores_gemma":[0.9996893,0.00006125249,0.0001244959,0.00001665405,0.00001955322,0.00008871133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03369157,0.002556057,0.3683079,0.0003614713,0.0005775907,0.001267364,0.0009281324,0.005443894,0.2758929,0.0003137455,0.003525388,0.3071339],"study_design_scores_gemma":[0.004912172,0.05619739,0.8469293,0.00006676703,0.0008932375,0.007627286,0.0002444779,0.009541939,0.06166273,0.0001983639,0.01166772,0.00005861233],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977847,0.001483866,0.0002607556,0.00007515342,0.000005433691,0.00002508053,0.00004097915,0.00002475767,0.0002992921],"genre_scores_gemma":[0.9986637,0.0004444686,0.0003561692,0.0000999397,0.00001821206,0.00002316599,0.0001578012,0.000007332033,0.0002292498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0007880086,"threshold_uncertainty_score":0.005717397,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05835483957096098,"score_gpt":0.439846833137735,"score_spread":0.381491993566774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}